Digital Health
ConcertAI’s TeraRecon Adds Mirada Medical to its AI Partner Program and Comprehensive Oncology Imaging Solutions
ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced the integration of MiradaXD, the multi-modality nuclear medicine…
ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced the integration of MiradaXD, the multi-modality nuclear medicine imaging software by Mirada Medical, into its AI partner program. This expands its ability to support cancer care providers with comprehensive oncology imaging solutions.
Recommended AI News: Plume Reveals the Latest Trends in the Wi-Fi-Connected VR Headset Market
Mirada Medical’s innovative software solutions, developed by world-leading experts in medical imaging, address a range of cancer-related challenges, from the automation of tumor segmentation and tracking to personalized treatment planning and response assessment. Mirada’s toolset streamlines workflow enabling clinicians to efficiently, accurately and quickly identify cancerous and healthy anatomy for optimal diagnosis. Physicians can easily communicate critical findings with the patients’ providers throughout the health system by exporting detailed tables, graphs as well as export of key images. Its wide range of clinical workflows allow quantitative PET/CT reading, hybrid PET/MR interpretation and software-based PET/MR and SPECT/MR fusion and more making Mirada a mission critical solution.
“We are thrilled to partner with TeraRecon to bring our solutions to a wider audience of cancer care providers,” said Jon DeVries, CEO of Mirada Medical. “TeraRecon’s Intuition is a highly innovative solution that perfectly complements our technology, enabling seamless integration into clinical workflows and delivering clear value to oncology patients and clinicians alike. Clinicians will also now be able to access longitudinal patient data, ultimately empowering them to offer better, personalized care.”
Recommended AI News: Plume Launches Uprise to Transform Connectivity Services for MDUs
TeraRecon’s Intuition solution offers a comprehensive suite of advanced visualization and clinical workflow tools, designed to optimize the use of medical imaging data across multiple care settings. With the integration of Mirada Medical’s solutions, Intuition now provides a more complete and personalized oncology imaging offering, enabling more accurate and efficient diagnosis, treatment planning, and monitoring of cancer patients.
“We are excited to join forces with Mirada Medical to bring the best of both companies’ solutions to the market,” said Dan McSweeney, President and CEO of TeraRecon. “Our shared mission is to provide innovative technologies that help improve patient outcomes and enhance clinician experience. We believe that the integration of Mirada’s multi modality imaging solutions into Intuition will be a game-changer for cancer care providers, offering a unique combination of advanced visualization and our AI-powered analytics.”
Recommended AI News: Codoxo Launches Generative AI for Healthcare Payment Integrity
[To share your insights with us, please write to sghosh@martechseries.com]
The post ConcertAI’s TeraRecon Adds Mirada Medical to its AI Partner Program and Comprehensive Oncology Imaging Solutions appeared first on AiThority.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
